The Immunological Contribution to Heterotopic Ossification Disorders

Michael R. Convente, Haitao Wang, Robert Pignolo, Frederick S. Kaplan, Eileen M. Shore

Research output: Contribution to journalReview article

31 Citations (Scopus)

Abstract

The formation of bone outside the endogenous skeleton is a significant clinical event, rendering affected individuals with immobility and a diminished quality of life. This bone, termed heterotopic ossification (HO), can appear in patients following invasive surgeries and traumatic injuries, as well as progressively manifest in several congenital disorders. A unifying feature of both genetic and nongenetic episodes of HO is immune system involvement at the early stages of disease. Activation of the immune system sets the stage for the downstream anabolic events that eventually result in ectopic bone formation, rendering the immune system a particularly appealing site of early therapeutic intervention for optimal management of disease. In this review, we will discuss the immunological contributions to HO disorders, with specific focus on contributing cell types, signaling pathways, relevant in vivo animal models, and potential therapeutic targets.

Original languageEnglish (US)
Pages (from-to)116-124
Number of pages9
JournalCurrent Osteoporosis Reports
Volume13
Issue number2
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Heterotopic Ossification
Immune System
Osteogenesis
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Disease Management
Skeleton
Animal Models
Quality of Life
Bone and Bones
Wounds and Injuries
Therapeutics

Keywords

  • Chemokines
  • Complement
  • Cytokines
  • Fibrodysplasia ossificans progressiva
  • Heterotopic ossification
  • Immune system
  • Lymphocytes
  • Macrophages
  • Mast cells
  • Progressive osseous heteroplasia

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

The Immunological Contribution to Heterotopic Ossification Disorders. / Convente, Michael R.; Wang, Haitao; Pignolo, Robert; Kaplan, Frederick S.; Shore, Eileen M.

In: Current Osteoporosis Reports, Vol. 13, No. 2, 01.01.2015, p. 116-124.

Research output: Contribution to journalReview article

Convente, Michael R. ; Wang, Haitao ; Pignolo, Robert ; Kaplan, Frederick S. ; Shore, Eileen M. / The Immunological Contribution to Heterotopic Ossification Disorders. In: Current Osteoporosis Reports. 2015 ; Vol. 13, No. 2. pp. 116-124.
@article{1fa943afd79c46b5a5c318119420570c,
title = "The Immunological Contribution to Heterotopic Ossification Disorders",
abstract = "The formation of bone outside the endogenous skeleton is a significant clinical event, rendering affected individuals with immobility and a diminished quality of life. This bone, termed heterotopic ossification (HO), can appear in patients following invasive surgeries and traumatic injuries, as well as progressively manifest in several congenital disorders. A unifying feature of both genetic and nongenetic episodes of HO is immune system involvement at the early stages of disease. Activation of the immune system sets the stage for the downstream anabolic events that eventually result in ectopic bone formation, rendering the immune system a particularly appealing site of early therapeutic intervention for optimal management of disease. In this review, we will discuss the immunological contributions to HO disorders, with specific focus on contributing cell types, signaling pathways, relevant in vivo animal models, and potential therapeutic targets.",
keywords = "Chemokines, Complement, Cytokines, Fibrodysplasia ossificans progressiva, Heterotopic ossification, Immune system, Lymphocytes, Macrophages, Mast cells, Progressive osseous heteroplasia",
author = "Convente, {Michael R.} and Haitao Wang and Robert Pignolo and Kaplan, {Frederick S.} and Shore, {Eileen M.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/s11914-015-0258-z",
language = "English (US)",
volume = "13",
pages = "116--124",
journal = "Current Osteoporosis Reports",
issn = "1544-1873",
publisher = "Current Science, Inc.",
number = "2",

}

TY - JOUR

T1 - The Immunological Contribution to Heterotopic Ossification Disorders

AU - Convente, Michael R.

AU - Wang, Haitao

AU - Pignolo, Robert

AU - Kaplan, Frederick S.

AU - Shore, Eileen M.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The formation of bone outside the endogenous skeleton is a significant clinical event, rendering affected individuals with immobility and a diminished quality of life. This bone, termed heterotopic ossification (HO), can appear in patients following invasive surgeries and traumatic injuries, as well as progressively manifest in several congenital disorders. A unifying feature of both genetic and nongenetic episodes of HO is immune system involvement at the early stages of disease. Activation of the immune system sets the stage for the downstream anabolic events that eventually result in ectopic bone formation, rendering the immune system a particularly appealing site of early therapeutic intervention for optimal management of disease. In this review, we will discuss the immunological contributions to HO disorders, with specific focus on contributing cell types, signaling pathways, relevant in vivo animal models, and potential therapeutic targets.

AB - The formation of bone outside the endogenous skeleton is a significant clinical event, rendering affected individuals with immobility and a diminished quality of life. This bone, termed heterotopic ossification (HO), can appear in patients following invasive surgeries and traumatic injuries, as well as progressively manifest in several congenital disorders. A unifying feature of both genetic and nongenetic episodes of HO is immune system involvement at the early stages of disease. Activation of the immune system sets the stage for the downstream anabolic events that eventually result in ectopic bone formation, rendering the immune system a particularly appealing site of early therapeutic intervention for optimal management of disease. In this review, we will discuss the immunological contributions to HO disorders, with specific focus on contributing cell types, signaling pathways, relevant in vivo animal models, and potential therapeutic targets.

KW - Chemokines

KW - Complement

KW - Cytokines

KW - Fibrodysplasia ossificans progressiva

KW - Heterotopic ossification

KW - Immune system

KW - Lymphocytes

KW - Macrophages

KW - Mast cells

KW - Progressive osseous heteroplasia

UR - http://www.scopus.com/inward/record.url?scp=84925534285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925534285&partnerID=8YFLogxK

U2 - 10.1007/s11914-015-0258-z

DO - 10.1007/s11914-015-0258-z

M3 - Review article

C2 - 25687936

AN - SCOPUS:84925534285

VL - 13

SP - 116

EP - 124

JO - Current Osteoporosis Reports

JF - Current Osteoporosis Reports

SN - 1544-1873

IS - 2

ER -